How is Breast Cancer Linked to Belviq?

In early June of 2020, a Louisiana woman filed a lawsuit against the manufacturers of the weight loss drugs Belviq (lorcaserin) and Belviq XR to seek compensation for her breast cancer. She began taking the drug in August 2018 through at least that same October. In June of 2019, she was diagnosed with breast cancer, alleging that it was a direct result of exposure to Belviq.

There have been many cancer suits against lorcaserin manufacturers since the US Food and Drug Administration (FDA) requested its removal from the market in February 2020. The order was given based on clinical trials showing that Belviq increased a patient’s risk of cancer, most often colorectal, lung, and pancreatic cancer.

How is Breast Cancer Linked to Belviq?

Belviq was developed as a medication to be taken jointly with practicing other facets of weight-loss therapy, such as a low-calorie diet and increased physical movement. It was created to help patients lose weight by reducing their hunger so they could more easily abide by their diet guidelines.

Lorcaserin was initially rejected by the FDA in 2010, after research showed that rats treated with the drug had an increased incidence of brain tumors and breast cancer. The FDA approved Belviq in 2012 but only if the drug manufacturer conducted a placebo-controlled, double-blind clinical trial to prove the drug’s safety. The study ran after the approval, from 2013-2018, and showed that more patients who took lorcaserin were diagnosed with cancer over those who took the placebo.

How can we help you?

Breast cancer victims all over the country are filing lawsuits against Belviq manufacturers for causing their diagnosis. These cases accuse lorcaserin manufacturers of failing to conduct proper safety research, failing to publicly recognize the link between Belviq and cancer, and intentionally delaying its removal from the market.

In addition to breast cancer, the cancers most frequently diagnosed in those who took Belviq are:

  • Colorectal cancer
  • Lung cancer
  • Pancreatic cancer

Although Belviq is no longer available, it may be too late for those already taking the drug in the past. If you or a loved one were diagnosed with breast cancer or another cancer after taking lorcaserin, the experienced legal team at Kwartler Manus, LLC. can assist you with the complicated process and help you get the compensation you deserve. Contact us online today for a free consultation to discuss your situation.

Categories
Related Posts
Put Us On Your Side
Name(Required)

I confirm I want to opt-in and receive news and marketing communication.
Text Marketing Terms and Conditions: We are using a text messaging platform, which is subject to the following terms and conditions. By opting-in for our text marketing and notifications in, you agree to these terms and conditions. By entering your phone number, you agree that we may send you text notifications and text marketing. You acknowledge that consent is not a condition for any purchase. This data will be used for sending you targeted marketing messages and notifications. Upon sending the text messages, your phone number will be passed to a text messages operator to fulfill their delivery. If you wish to unsubscribe from receiving text marketing messages and notifications reply with STOP to any mobile message sent from us or use the unsubscribe link we provided you with in any of our messages. You understand and agree that alternative methods of opting out, such as using alternative words or requests will not be accounted as a reasonable means of opting out. Message and data rates may apply. For any questions please text "HELP" to the number you received the messages from. You can also contact us for more information. If you wish to opt out please follow the procedures above.